via University of Oxford
Scientists have developed a world-first diagnostic test, powered by artificial intelligence, that can identify known respiratory viruses within five minutes from just one nasal or throat swab.
The new diagnostic test could replace current methods that are limited to testing for only one infection, such as a lateral flow test for COVID-19, or otherwise are either lab-based and time-consuming or fast and less accurate.
The new virus detection and identification methodology is described in a paper published in ACS Nano, authored by DPhil student Nicolas Shiaelis and Professor Achillefs Kapanidis from the Department of Physics, and Dr Nicole Robb from the University of Warwick who is a Visiting Lecturer at Oxford’s Department of Physics.
The paper demonstrates how machine learning can significantly improve the efficiency, accuracy and time taken to not only identify different types of viruses, but also differentiate between strains.
Nicolas Shiaelis and Dr Robb collaborated with the John Radcliffe Hospital to validate the new method. The ground-breaking testing technology combines molecular labelling, computer vision and machine learning to create a universal diagnostic imaging platform that looks directly at a patient sample and can identify which pathogen is present in a matter of seconds – much like facial recognition software, but for germs.
Preliminary research demonstrated that the test could identify the COVID-19 virus in patient samples and further work determined that the test could be used to diagnose multiple respiratory infections, within five minutes and with over 97% accuracy.
Dr Robb and Nicolas Shiaelis founded Pictura Bio, a University of Oxford spinout, that now licences the technology. They are now looking for further investment to accelerate development and get it to the front line of healthcare.
‘Our aim at Pictura Bio is to turn the method into a diagnostic test by creating a dedicated imager and single-use cartridge for use in point-of-care testing, with limited input from the user. We are also expanding the number of viruses that the models are trained on and will eventually start looking at other pathogens, such as bacteria and fungi, in respiratory samples, blood and urine.’
Dr Robb said: ‘Cases of respiratory infections this winter have hit record-breaking highs, increasing the number of people seeking medical help. This combined with the COVID-19 backlog, staff shortages, tighter budgets and an ageing population puts the NHS and its workforce under immense and unsustainable pressure.
‘Our simplified method of diagnostic testing is quicker and more cost-effective, accurate and future proof than any other tests currently available. If we want to detect a new virus, all we need to do is retrain the software to recognise it, rather than develop a whole new test. Our findings demonstrate the potential for this method to revolutionise viral diagnostics and our ability to control the spread of respiratory illnesses.’
Original Article: Oxford scientists develop test that can identify respiratory viruses within five minutes
More from: University of Oxford | University of Warwick
The Latest Updates from Bing News
Go deeper with Bing News on:
Respiratory virus test
- What’s Going Around: Winter virus going into overtime this spring especially if you have kids at home
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.
- More Layoffs Signal COVID-19 Testing Boom Is Over
Abbott Laboratories is the latest company to eliminate positions related to a severe decline in the COVID-19 testing demand.
- Low level of respiratory virus shedding found among sporthorses at a long summer show
The authors noted that most outbreaks associated with respiratory pathogens in performance horses at large events are often been reported during the colder months.
- Fever: Common Non-respiratory Feature of SARS-CoV-2 Infection
Fever is the most widespread non-respiratory feature of infection with SARS-CoV-2, the virus that causes COVID-19 (1 Trusted ... The scientists applied statistical tests to determine the relationship ...
- Hologic (HOLX) Gets FDA Nod for Multiplexed Respiratory Test
Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.
Go deeper with Bing News on:
- My grandmother chose euthanasia after getting a cancer diagnosis. I made TikToks about my last visit with her.
This is the story of what happened when she went viral, as told to Charissa Cheong. A month and a half ago, I found out that my grandmother had stage 4 ovarian cancer. When we were informed as a ...
- My grandmother chose euthanasia after getting a cancer diagnosis. She shared why with me on TikTok.
Ali Tate Cutler interviewed her grandmother about her euthanasia choice on TikTok. The decision sparked a viral conversation about death.
- ‘These last four days have been so hard’ – Model explains why she made viral TikToks of her grandmother’s choice to die
A Victoria’s Secret model has revealed why it was important for her to document the last days she’ll spend with her terminally ill grandmother after the 85-year-old decided to seek euthanasia to end ...
- Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution
Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up detection measures for hepatitis ...
- After A Sudden Medical Diagnosis, Radical Self-Acceptance Was My Only Option
Last year, two weeks before Christmas, my face broke. I’d been going about my usual business — parenting, working, grocery shopping — when I began to notice a little tension on the right-hand side of ...